Aim & Scope
CSK Journal of Diabetes Research, Reviews and Reportsaims to provide a multidisciplinary platform for professionals, research scholars, and scientists to publish innovative research in the field of Diabetes Research. Manuscripts submitted to the journal must adhere to the ICMJE guidelines (CONSORT) for conducting and reporting clinical trials. The authors are required to ensure that proper protocols were followed during the clinical trials, and that informed consent was obtained from each participant before the trial began. The trial must also be approved by an ethics committee and monitored appropriately.
The journal welcomes original research articles, review articles, special articles, brief reports, clinical reports, and short communications related to the latest advancements in Diabetes Research. All case studies or clinical trial reports must adhere to the guidelines for statistical analysis and reporting of trial results (SAMPL). If necessary, the authors must be prepared to provide the editorial board with the informed consent form and other ethical approval forms.
To ensure the quality of the published articles, all scientific manuscripts undergo a rigorous peer-review process by expert reviewers and the most distinguished editors on our editorial board. The journal follows the Creative Commons Attribution License and offers open-access publishing policies to scholars. The published articles can be accessed by readers online using a unique Digital Objective Identifier (DOI) provided by Cross Ref.
